Audrey Thomas Schoemann

Audrey Thomas Schoemann

UNVERIFIED PROFILE

Are you Audrey Thomas Schoemann?   Register this Author

Register author
Audrey Thomas Schoemann

Audrey Thomas Schoemann

Publications by authors named "Audrey Thomas Schoemann"

38Publications

1243Reads

46Profile Views

1PubMed Central Citations

Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients.

Clin Genitourin Cancer 2020 Apr 13;18(2):155-160. Epub 2019 Jun 13.

Pharmacokinetics and Pharmacochemistry Unit, Cochin Hospital, Paris Descartes University, AP-HP, Paris, France; Inserm U1268, CiTCom UMR8038 CNRS, Pharmacy UFR, University of Paris Descartes, PRES sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.05.020DOI Listing
April 2020

The impact of body composition parameters on severe toxicity of nivolumab.

Eur J Cancer 2020 Jan 30;124:170-177. Epub 2019 Nov 30.

Department of Medical Oncology, Cochin Hospital, AP-HP 5, CARPEM, CERTIM, Paris, France; Laboratory of Biological Nutrition EA, Pharmacy University, Université Paris Descartes, 4466, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.11.003DOI Listing
January 2020

Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients.

Clin Ther 2019 05 17;41(5):882-896.e3. Epub 2019 Apr 17.

Département de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; UMR8638 CNRS, UFR Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01492918193012
Publisher Site
http://dx.doi.org/10.1016/j.clinthera.2019.03.006DOI Listing
May 2019

Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.

Clin Pharmacokinet 2019 04;58(4):451-467

UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-018-0703-0
Publisher Site
http://dx.doi.org/10.1007/s40262-018-0703-0DOI Listing
April 2019

Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study.

Endocr Connect 2018 Dec;7(12):1409-1414

Pharmacokinetics and Pharmacochemistry Unit, Cochin Hospital, Paris Descartes University, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EC-18-0428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301193PMC
December 2018

Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences.

Crit Rev Oncol Hematol 2018 Sep 9;129:102-112. Epub 2018 Jul 9.

Centre d'Étude et de Recours aux Inhibiteurs de l'Angiogénèse, GH Cochin Port-Royal, HUPC, AP-HP, Paris Descartes, 75014 Paris, France; UF de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, AP-HP, Paris Descartes, CARPEM, 75014 Paris, France; UMR8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.06.015DOI Listing
September 2018

Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study.

Fundam Clin Pharmacol 2018 Feb 10;32(1):98-107. Epub 2017 Nov 10.

Department of Medical Oncology, Cochin Hospital, AP-HP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/fcp.12327DOI Listing
February 2018

Letter to the editor regarding the paper by Loquai C et al. 'Use of complementary and alternative medicine: a multicenter cross-sectional study in 1089 melanoma patients'.

Eur J Cancer 2017 11 3;85:158-159. Epub 2017 Sep 3.

Assistance publique des Hôpitaux de Paris, Biologie du médicament et toxicologie, Hôpital Cochin, Paris, France; Groupe de Pharmacologie Clinique Oncologique, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.07.035DOI Listing
November 2017

Individualized Pazopanib Dosing-Letter.

Clin Cancer Res 2017 10;23(20):6377

Department of Pharmacokinetics and Pharmacochemisty, Hôpital Cochin, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1873DOI Listing
October 2017

ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.

Tumour Biol 2017 Jul;39(7):1010428317716077

3 Département de Pharmacie Clinique, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1010428317716077DOI Listing
July 2017

Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients.

J Pharm Biomed Anal 2017 May 24;139:30-36. Epub 2017 Feb 24.

Department of Pharmacokinetics and Pharmacochemistry, Hôpital Cochin, AP-HP, Paris, France; Immunomodulatory Therapies Multidisciplinary Study group (CERTIM), Hôpital Cochin, AP-HP, Paris, France; Groupe de Pharmacologie Clinique Oncologique (GPCO), Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2017.02.041DOI Listing
May 2017

Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old.

Invest New Drugs 2017 04 29;35(2):242-246. Epub 2016 Oct 29.

Department of Medical Oncology, Cochin - Port Royal Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité 123, Boulevard de Port-Royal, 75014, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0400-5DOI Listing
April 2017

Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.

Expert Opin Drug Metab Toxicol 2016 Dec 24;12(12):1433-1444. Epub 2016 Aug 24.

a Department of Medical Oncology, CERIA , Paris Descartes University, AP-HP, Cochin Hospital , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2016.1225038DOI Listing
December 2016

Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients.

Pharmacol Res 2016 11 1;113(Pt A):709-718. Epub 2016 Jul 1.

Assistance Publique Hôpitaux de Paris, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.06.032DOI Listing
November 2016

[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management].

Bull Cancer 2016 Mar 29;103(3):259-72. Epub 2016 Jan 29.

Hôpitaux universitaires Paris centre, université Paris Descartes, CERIA, Center for Research on Angiogenesis Inhibitors, ARIANE, hôpital Broca, hôpital Cochin-Port-Royal, service d'oncologie médicale, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.10.020DOI Listing
March 2016

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.

Expert Opin Investig Drugs 2015 May 20;24(5):673-87. Epub 2015 Jan 20.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.2015.10
Publisher Site
http://dx.doi.org/10.1517/13543784.2015.1005736DOI Listing
May 2015

Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib.

Expert Opin Drug Metab Toxicol 2015 May 25;11(5):785-94. Epub 2015 Mar 25.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France 33 1 58 41 17 46 ; 33 1 58 41 17 45 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2015.1030392DOI Listing
May 2015

A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer.

J Chromatogr B Analyt Technol Biomed Life Sci 2015 May 9;989:86-90. Epub 2015 Mar 9.

Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2015.03.001DOI Listing
May 2015

Sorafenib for patients with differentiated thyroid cancer.

Lancet 2015 Jan;385(9964):227-8

Medical Oncology and Pharmacology, CERIA, Cochin-Port Royal Hospital, AP-HP, Paris, 75014, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60054-XDOI Listing
January 2015

Sorafenib in thyroid cancer patients: learning from toxicity.

Oncologist 2014 Aug 22;19(8):e3. Epub 2014 Jul 22.

Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA), Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122476PMC
August 2014

Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.

Expert Opin Drug Saf 2014 May 3;13(5):663-73. Epub 2014 Apr 3.

Paris Descartes University, Cochin Hospital, AP-HP, Medical Oncology Department, Angiogenesis Inhibitors Multidisciplinary Study Group (CERIA) , Paris , France +33 1 58 41 17 46 ; +33 1 58 41 17 45 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2014.90
Publisher Site
http://dx.doi.org/10.1517/14740338.2014.907270DOI Listing
May 2014

Drug interactions with solid tumour-targeted therapies.

Crit Rev Oncol Hematol 2014 Jan 28;89(1):179-96. Epub 2013 Aug 28.

Centre d'Étude et de Recours aux Inhibiteurs de l'Angiogénèse, Paris, France; Service d'Oncologie Médicale, Groupement des Hôpitaux Paris Centre, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.08.007DOI Listing
January 2014

An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients.

J Chromatogr B Analyt Technol Biomed Life Sci 2013 Jun 25;928:93-7. Epub 2013 Mar 25.

Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2013.03.017DOI Listing
June 2013

A new strategy to target regulatory T cells in solid tumors.

Oncoimmunology 2013 Mar;2(3):e23338

Université Paris Descartes ; Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques; Paris, France ; Université Paris Descartes; Sorbonne Paris Cité; Faculté de Médecine; Paris, France ; Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie; Assistance Publique-Hôpitaux de Paris; Hôpital Cochin; Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.23338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661163PMC
March 2013

Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.

J Immunol 2012 Dec 26;189(11):5171-7. Epub 2012 Oct 26.

Université Paris Descartes, Sorbonne Paris Cité, Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1103094
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1103094DOI Listing
December 2012

Bystander effect of vinorelbine alters antitumor immune response.

Int J Cancer 2011 Sep 1;129(6):1511-8. Epub 2011 Apr 1.

Université Paris Descartes, Faculté de Médecine, EA 1833, AP-HP Hôpital Cochin, Paris cedex 14, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.25813
Publisher Site
http://dx.doi.org/10.1002/ijc.25813DOI Listing
September 2011